<?xml version="1.0" encoding="UTF-8"?>
<rss xmlns:atom="http://www.w3.org/2005/Atom" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:media="http://search.yahoo.com/mrss/" version="2.0">
  <channel>
    <title>Hep-C</title>
    <link>https://www.hppr.org/tags/hep-c</link>
    <description>Hep-C</description>
    <language>en-US</language>
    <copyright>Copyright</copyright>
    <lastBuildDate>Mon, 05 Oct 2020 07:52:00 GMT</lastBuildDate>
    <atom:link href="https://www.hppr.org/tags/hep-c.rss" type="application/rss+xml" rel="self" />
    <item>
      <title>3 Scientists Win Nobel Prize For Hepatitis C Virus Discovery</title>
      <link>https://www.hppr.org/hppr-news/2020-10-05/3-scientists-win-nobel-prize-for-hepatitis-c-virus-discovery</link>
      <description>The scientists' work led to a test to protect blood transfusion recipients from hepatitis C and drugs to treat the infection that have saved millions of lives, according to the Nobel Assembly.</description>
      <pubDate>Mon, 05 Oct 2020 07:52:00 GMT</pubDate>
      <guid>https://www.hppr.org/hppr-news/2020-10-05/3-scientists-win-nobel-prize-for-hepatitis-c-virus-discovery</guid>
      <dc:creator>Rob Stein, Mark Katkov</dc:creator>
      <media:thumbnail url="https://npr.brightspotcdn.com/dims4/default/8b82506/2147483647/strip/false/crop/515x289+0+0/resize/300x168!/quality/90/?url=https%3A%2F%2Fmedia.npr.org%2Fassets%2Fimg%2F2020%2F10%2F05%2Fnobel16_slideshow_wide-0afd4acc4857169ed4e894c12723173be9a6d8a4.jpg" />
      <media:content type="image/jpeg" url="https://npr.brightspotcdn.com/dims4/default/ba40c92/2147483647/strip/false/crop/515x289+0+0/resize/515x289!/quality/90/?url=https%3A%2F%2Fmedia.npr.org%2Fassets%2Fimg%2F2020%2F10%2F05%2Fnobel16_slideshow_wide-0afd4acc4857169ed4e894c12723173be9a6d8a4.jpg" />
    </item>
    <item>
      <title>Kansas Agrees To Cover Potentially Life-Saving Drugs For Patients With Chronic Hepatitis C</title>
      <link>https://www.hppr.org/hppr-news/2018-11-20/kansas-agrees-to-cover-potentially-life-saving-drugs-for-patients-with-chronic-hepatitis-c</link>
      <description>Kansas has agreed to cover the cost of drugs to treat Medicaid patients with chronic hepatitis C without subjecting them to a lengthy list of...</description>
      <pubDate>Tue, 20 Nov 2018 20:46:35 GMT</pubDate>
      <guid>https://www.hppr.org/hppr-news/2018-11-20/kansas-agrees-to-cover-potentially-life-saving-drugs-for-patients-with-chronic-hepatitis-c</guid>
      <dc:creator>Dan Margolies</dc:creator>
      <media:thumbnail url="https://npr.brightspotcdn.com/dims4/default/dd12ce3/2147483647/strip/false/crop/1600x1067+0+0/resize/300x200!/quality/90/?url=https%3A%2F%2Fmediad.publicbroadcasting.net%2Fp%2Fkcur%2Ffiles%2F201811%2Fhepatitis_c.jpg" />
      <media:content type="image/jpeg" url="https://npr.brightspotcdn.com/dims4/default/66ee00b/2147483647/strip/false/crop/1600x1067+0+0/resize/792x528!/quality/90/?url=https%3A%2F%2Fmediad.publicbroadcasting.net%2Fp%2Fkcur%2Ffiles%2F201811%2Fhepatitis_c.jpg" />
    </item>
  </channel>
</rss>
